Showing results (141-150 of 452) with videos related to
Sort By:
Pageof 46
Current Radiopharmaceuticals|March 16, 2015
Indirect Production of No Carrier Added (NCA) (177)Lu from Irradiation of Enriched (176)Yb: Options for Ytterbium/Lutetium SeparationAshutosh Dash, Rubel Chakravarty, Furn F Russ Knapp, et al.Current Radiopharmaceuticals|March 16, 2015
Chemistry and bifunctional chelating agents for binding (177)LuJózef L Parus, Dariusz Pawlak, Renata Mikolajczak, et al.Current Radiopharmaceuticals|May 23, 2023
A New Buffer for Gallium-68 Labeling Suitable for use in Nuclear Medicine; Triethanolamine (TEA)Ayşe Uğur, Olga Yaylali, Doğangün YükselCurrent Radiopharmaceuticals|May 23, 2023
Evaluation of Bone Scan Index as a Prognostic Tool in Breast Cancer Patients with Bone MetastasisMaria Silvia De Feo, Viviana Frantellizzi, Arianna Di Rocco, et al.Current Radiopharmaceuticals|July 23, 2020
Gonioprobe, an Innovative Gamma-probe to Guide Parathyroid Radioguided Surgery: First Clinical Experiences with Navigator and Lock-ontarget FunctionsMarco Bononi, Frantellizzi Viviana, Maria Silvia De Feo, et al.Current Radiopharmaceuticals|December 24, 2011
PET measurements of cAMP-mediated phosphodiesterase-4 with (R)-[11C]rolipramMiran Kenk, Adam Thomas, Mireille Lortie, et al.Current Radiopharmaceuticals|December 24, 2011
Utility of γH2AX as a molecular marker of DNA double-strand breaks in nuclear medicine: applications to radionuclide therapy employing auger electron-emitting isotopesLi-Jeen Mah, Christian Orlowski, Katherine Ververis, et al.Current Radiopharmaceuticals|December 24, 2011
Radiobromine-labelled tracers for positron emission tomography: possibilities and pitfallsVladimir TolmachevCurrent Radiopharmaceuticals|December 24, 2011
PET tracers based on (86)YJinming Huang, Liyang Cui, Fan Wang, et al.Current Radiopharmaceuticals|December 29, 2011
Protein targeting constructs in alpha therapyTove Olafsen, Jorgen Elgqvist, Anna M WuPageof 46